TALIS BIOMEDICAL CORP
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TLIS and buy or sell other stocks, ETFs, and their options commission-free!About TLIS
Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Redwood City, CA.
CEORobert J. Kelley
CEORobert J. Kelley
Employees102
Employees102
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2013
Founded2013
Employees102
Employees102
TLIS Key Statistics
Market cap161.15M
Market cap161.15M
Price-Earnings ratio-2.04
Price-Earnings ratio-2.04
Dividend yield—
Dividend yield—
Average volume189.08K
Average volume189.08K
High today$2.84
High today$2.84
Low today$1.65
Low today$1.65
Open price$2.80
Open price$2.80
Volume59.11K
Volume59.11K
52 Week high$2.84
52 Week high$2.84
52 Week low$0.421
52 Week low$0.421
Stock Snapshot
The current TALIS BIOMEDICAL CORP(TLIS) stock price is $2.84, with a market capitalization of 161.15M. The stock trades at a price-to-earnings (P/E) ratio of -2.04.
On 2025-12-18, TALIS BIOMEDICAL CORP(TLIS) stock moved within a range of $1.65 to $2.84. With shares now at $2.84, the stock is trading +72.1% above its intraday low and 0.0% below the session's peak.
Trading volume for TALIS BIOMEDICAL CORP(TLIS) stock has reached 59.11K, versus its average volume of 189.08K.
Over the past 52 weeks, TALIS BIOMEDICAL CORP(TLIS) stock has traded between a high of $2.84 and a low of $0.42.
Over the past 52 weeks, TALIS BIOMEDICAL CORP(TLIS) stock has traded between a high of $2.84 and a low of $0.42.
People also own
Based on the portfolios of people who own TLIS. This list is generated using Robinhood data, and it’s not a recommendation.